The imPulse® System is Level 42 AI’s sensing platform for collecting Vibrome® biosignatures. The public site presents it as part of a broader health-information approach that combines sensor fusion with interpretable algorithms.

imPulse® UNA is presented on the Level 42 AI® website as a point-of-care system available with Panasonic® Toughbook and Lenovo® K11 Tablet options. Current availability and configuration should be confirmed directly with the Level 42 AI® team.

The website describes broad frequency-bandwidth sensing from infrasonic to ultrasonic ranges. The signals collected and the resulting analysis depend on the configured device, workflow and validated application.

Level 42 AI® describes its platform as non-invasive, including contact and contactless sensor-fusion capabilities. The appropriate method and use limitations depend on the product configuration and deployment setting.

Yes. The Level 42 AI® website invites enquiries about clinical research collaboration. Research scope, protocol, ethics review, data governance and validation requirements should be agreed before a study begins.

Use the Level 42 AI® contact form and select the relevant interest, such as imPulse® UNA, pre-purchase or clinical research collaboration. The team can confirm current options, configuration and next steps.

The products page lists imPulse® UNA with a Panasonic® Toughbook or Lenovo® K11 Tablet. Exact hardware, accessories, software and regional availability should be confirmed before purchase.

Level 42 AI® describes software-defined contact and contactless sensor-fusion approaches. The available mode depends on the particular system, sensor arrangement and intended workflow.

Signal quality can be affected by sensor placement, environmental noise, movement, hardware condition, workflow consistency and operator training. Quality checks should be completed before interpreting results.

No. imPulse® provides biosignature information and should be used within its validated purpose. Healthcare professionals should decide whether medical imaging, laboratory testing or other clinical assessment is required.